|
Market Closed -
NYSE
01:00:02 19/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 81.35 USD | -5.20% |
|
-9.13% | +2.51% |
| 11-19 | Health Care Down as Insurers Slide -- Health Care Roundup | DJ |
| 11-18 | UnitedHealthcare to expand program paying pharmacists for medical services | RE |
| Market Cap | 104B 94.93B 87.77B 79.21B 149B 9,726B 155B 1,060B 419B 5,250B 390B 382B 16,578B | P/E 2026 * |
11.6x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 157B 143B 133B 120B 225B 14,695B 234B 1,602B 633B 7,932B 590B 578B 25,047B | EV / Sales 2026 * |
0.37x | EV / Sales 2027 * | 0.35x |
| Free-Float |
71.21% | Yield 2026 * |
3.26% | Yield 2027 * | 3.35% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
| CVS | Real-time | ||
| CVS * | End-of-day quote | ||
| CVS | Real-time | ||
| 0HRS | Delayed | ||
| CVS | Real-time | ||
| CVSUS | End-of-day quote | ||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | Delayed | ||
| CVS | End-of-day quote | ||
| CVS | End-of-day quote | ||
| 1CVS | End-of-day quote | ||
| CVSCL | End-of-day quote | ||
| 0HRS | Real-time | ||
| Real-time | |||
| CVS | Delayed | ||
| CVS | Delayed |
Last Transcript: CVS Health Corporation
| 1 day | -5.20% | ||
| 1 week | -9.13% | ||
| Current month | -9.86% | ||
| 1 month | -11.92% | ||
| 3 months | -14.29% | ||
| 6 months | -15.25% | ||
| Current year | +2.51% |
| 1 week | 81.09 | 90.71 | |
| 1 month | 77.33 | 95.26 | |
| Current year | 69.51 | 110.68 | |
| 1 year | 69.51 | 110.68 | |
| 3 years | 43.56 | 110.68 | |
| 5 years | 43.56 | 111.25 | |
| 10 years | 43.56 | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 17/10/2024 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 73 | 20/01/2011 |
| Director/Board Member | 71 | 05/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/11/26 | Buy | Executive/Senior Manager | 23,855 | 0.0019% | ||
| 31/05/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 31/05/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.20% | -9.13% | +4.38% | +18.22% | 110B | ||
| -4.96% | -5.87% | -0.37% | +93.34% | 105B | ||
| +0.71% | -9.48% | +35.50% | +440.92% | 41.68B | ||
| -0.73% | +1.02% | +12.24% | +95.31% | 33.35B | ||
| +0.69% | -0.39% | +42.71% | +75.13% | 29.9B | ||
| +1.30% | +0.39% | +40.13% | +92.52% | 28.2B | ||
| -3.80% | -7.38% | +40.59% | +325.70% | 22.45B | ||
| -1.37% | -1.74% | -19.35% | -20.58% | 19.79B | ||
| -0.25% | +0.77% | -4.24% | +32.77% | 17.18B | ||
| -2.13% | -5.89% | +116.61% | - | 14.55B | ||
| Average | -1.57% | -3.56% | +26.82% | +128.15% | 42B | |
| Weighted average by Cap. | -2.79% | -5.28% | +16.34% | +112.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 422B 385B 356B 321B 605B 39,438B 629B 4,298B 1,699B 21,287B 1,583B 1,550B 67,218B | 431B 393B 364B 328B 618B 40,315B 643B 4,394B 1,737B 21,760B 1,619B 1,585B 68,713B |
| Net income | 8.99B 8.19B 7.58B 6.84B 12.88B 840B 13.39B 91.5B 36.17B 453B 33.71B 33B 1,431B | 9.44B 8.61B 7.96B 7.19B 13.53B 882B 14.07B 96.16B 38.01B 476B 35.42B 34.68B 1,504B |
| Net Debt | 53.18B 48.5B 44.84B 40.47B 76.21B 4,969B 79.22B 542B 214B 2,682B 199B 195B 8,469B | 48.78B 44.48B 41.13B 37.12B 69.91B 4,558B 72.66B 497B 196B 2,460B 183B 179B 7,769B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | $81.35 | -5.20% | 17,587,940 |
| 17/11/26 | $85.81 | -3.14% | 13,620,793 |
| 16/11/26 | $88.59 | -0.85% | 11,780,922 |
| 13/11/26 | $89.35 | -0.49% | 8,019,995 |
| 12/11/26 | $89.79 | +0.30% | 11,792,301 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions

















